Suzhou Fengbei Biotech Stock Co.
603334.SS
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.03B
Close$
$13.11
61% downside
Current Fair Value
61% downsideOvervalued by 61% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.03 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $0.35 (1.06%) |
| Earnings per Share | $0.9 |
| Beta | 1.08 |
| Outstanding Shares | - |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 36.69 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Suzhou Fengbei Biotech Stock Co.
395 employees
CEO: Yin Li Suzhou Fengbei Biotech Stock Co., Ltd. centers its operations around the extensive repurposing of waste oil resources, also maintaining a division for oleochemicals. The company predominantly manufactures valuable products derived from r...